Etiology of Acute Myeloid Leukemia in the Elderly

Preiss, 2003, Cytogenetic findings in adult de novo acute myeloid leukaemia. A population-based study of 303/337 patients, Br J Haematol, 123, 219, 10.1046/j.1365-2141.2003.04568.x Moorman, 2001, Karyotype and age in acute myeloid leukemia. Are they linked?, Cancer Genet Cytogenet, 126, 155, 10.1016/S0165-4608(00)00414-3 Schoch, 2001, Dependence of age-specific incidence of acute myeloid leukemia on karyotype, Blood, 98, 3500, 10.1182/blood.V98.12.3500 Vickers, 2000, The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation, Leukemia, 14, 722, 10.1038/sj.leu.2401722 Cartwright, 2002, Sex ratios and the risks of haematological malignancies, Br J Haematol, 118, 1071, 10.1046/j.1365-2141.2002.03750.x Sanderson, 2006, Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemia, Leukemia, 10.1038/sj.leu.2404055 Pedersen-Bjergaard, 2002, Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia, Blood, 99, 1909, 10.1182/blood.V99.6.1909 Suzuki, 2005, Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia, Blood, 101, 2770 Schoch, 2005, Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile, Genes Chromosomes Cancer, 43, 227, 10.1002/gcc.20193 Valk, 2004, Prognostically useful gene-expression profiles in acute myeloid leukemia, N Engl J Med, 350, 1617, 10.1056/NEJMoa040465 Kottaridis, 2002, Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia, Blood, 100, 2393, 10.1182/blood-2002-02-0420 Richardson, 1992, Occupational risk factors for acute leukaemia, Int J Epidemiol, 21, 1063, 10.1093/ije/21.6.1063 Ciccone, 1993, Myeloid leukemias and myelodysplastic syndromes, Cancer Genet Cytogenet, 68, 135, 10.1016/0165-4608(93)90010-J Lazarov, 2000, Acute myeloid leukaemia and exposure to organic solvents—A case-control study, Eur J Epidemiol, 16, 295, 10.1023/A:1007618216958 Speer, 2002, Risk factors for acute myeloid leukemia and multiple myeloma, J Environ Health, 64, 9 Nisse, 2001, Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France, Br J Haematol, 112, 927, 10.1046/j.1365-2141.2001.02645.x Rigolin, 1998, Exposure to myelotoxic agents and myelodysplasia, Br J Haematol, 103, 189, 10.1046/j.1365-2141.1998.00963.x Bjork, 2000, Smoking and myelodysplastic syndromes, Epidemiology, 11, 285, 10.1097/00001648-200005000-00010 Aksoy, 1978, Followup study on the mortality and the development of leukemia in 44 pancytopenic patients with chronic exposure to benzene, Blood, 52, 285, 10.1182/blood.V52.2.285.285 Paustenbach, 1993, Benzene toxicity and risk assessment, 1972-1992, Environ Health Perspect, 101, 177, 10.1289/ehp.93101s6177 Smith, 1996, Mechanistic studies of benzene toxicity—Implications for risk assessment, Adv Exp Med Biol, 387, 259, 10.1007/978-1-4757-9480-9_34 Zeise, 2000, California perspective on the assessment of benzene toxicological risks, J Toxicol Environ Health A, 61, 479, 10.1080/00984100050166523 Hotz, 1997, Hematopoietic and lymphatic malignancies in vehicle mechanics, Crit Rev Toxicol, 27, 443, 10.3109/10408449709078443 Boffetta, 2004, Risk of acute myeloid leukemia after exposure to diesel exhaust, J Occup Environ Med, 46, 1076, 10.1097/01.jom.0000141669.08765.ab Smith, 1998, Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene, Cancer Res, 58, 2176 Zhang, 1998, Benzene metabolites induce the loss and long arm deletion of chromosomes 5 and 7 in human lymphocytes, Leuk Res, 22, 105, 10.1016/S0145-2126(97)00157-4 Smith, 2000, Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells, Carcinogenesis, 21, 1485, 10.1093/carcin/21.8.1485 Shimizu, 1990, Cancer risk among atomic bomb survivors. The RERF Life Span Study, JAMA, 264, 601, 10.1001/jama.264.5.601 Pearce, 1990, Follow up of New Zealand participants in British atmospheric nuclear weapons tests in the Pacific, BMJ, 300, 1161, 10.1136/bmj.300.6733.1161 Darby, 1993, Further follow up of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom’s atmospheric nuclear weapon tests and experimental programmes, BMJ, 307, 1530, 10.1136/bmj.307.6918.1530 Doody, 1998, Mortality among United States radiologic technologists, 1926-90, Cancer Causes Control, 9, 67, 10.1023/A:1008801404245 Cardis, 1995, Effects of low doses and low dose rates of external ionizing radiation, Radiat Res, 142, 117, 10.2307/3579020 Weiss, 1995, Leukemia mortality after x-ray treatment for ankylosing spondylitis, Radiat Res, 142, 1, 10.2307/3578960 Inskip, 1990, Leukemia following radiotherapy for uterine bleeding, Radiat Res, 122, 107, 10.2307/3577593 Urowitz, 1985, Myeloproliferative disorders in patients with rheumatoid arthritis treated with total body irradiation, Am J Med, 78, 60, 10.1016/0002-9343(85)90248-7 Inskip, 1993, Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease, Radiat Res, 135, 108, 10.2307/3578404 Griem, 1994, Cancer following radiotherapy for peptic ulcer, J Natl Cancer Inst, 86, 842, 10.1093/jnci/86.11.842 Travis, 1997, Risk of second malignant neoplasms among long-term survivors of testicular cancer, J Natl Cancer Inst, 89, 1429, 10.1093/jnci/89.19.1429 Curtis, 1992, Risk of leukemia after chemotherapy and radiation treatment for breast cancer, N Engl J Med, 326, 1745, 10.1056/NEJM199206253262605 Curtis, 1992, Risk of leukemia after chemotherapy and radiation treatment for breast cancer, N Engl J Med, 326, 1745, 10.1056/NEJM199206253262605 Armitage, 2003, Treatment-related myelodysplasia and acute leukemia in non-Hodgkin’s lymphoma patients, J Clin Oncol, 21, 897, 10.1200/JCO.2003.07.113 Gundestrup, 1999, Radiation-induced acute myeloid leukaemia and other cancers in commercial jet cockpit crew, Lancet, 354, 2029, 10.1016/S0140-6736(99)05093-X Ballard, 2000, Cancer incidence and mortality among flight personnel, Aviat Space Environ Med, 71, 216 Pukkala, 2003, Cancer incidence among 10,211 airline pilots, Aviat Space Environ Med, 74, 699 Reynolds, 1996, Genetic instability induced by the tumor microenvironment, Cancer Res, 56, 5754 Lorimore, 2001, Inflammatory-type responses after exposure to ionizing radiation in vivo, Oncogene, 20, 7085, 10.1038/sj.onc.1204903 Chen, 1998, A meta-analysis of painting exposure and cancer mortality, Cancer Detect Prev, 22, 533, 10.1046/j.1525-1500.1998.00A47.x Nilsson, 1998, Leukaemia, lymphoma, and multiple myeloma in seamen on tankers, Occup Environ Med, 55, 517, 10.1136/oem.55.8.517 Sathiakumar, 1998, Mortality from cancer and other causes of death among synthetic rubber workers, Occup Environ Med, 55, 230, 10.1136/oem.55.4.230 Metayer, 1998, Nested case-control study of tumors of the hemopoietic and lymphatic systems among workers in the meat industry, Am J Epidemiol, 147, 727, 10.1093/oxfordjournals.aje.a009517 Hayes, 1990, Mortality of U.S. embalmers and funeral directors, Am J Ind Med, 18, 641, 10.1002/ajim.4700180603 McDonald, 2001, Hypothesis, Leukemia, 15, 10, 10.1038/sj.leu.2401981 Ross, 2002, Diet and risk of leukemia in the Iowa Women’s Health Study, Cancer Epidemiol Biomarkers Prev, 11, 777 Hursting, 1993, Diet and human leukemia—An analysis of international data, Prevent Med, 22, 409, 10.1006/pmed.1993.1034 Kane, 1999, Tobacco and the risk of acute leukaemia in adults, Br J Cancer, 81, 1228, 10.1038/sj.bjc.6690833 Bjork, 2001, Smoking and acute myeloid leukemia, Leuk Res, 25, 865, 10.1016/S0145-2126(01)00048-0 Korte, 2000, The contribution of benzene to smoking-induced leukemia, Environ Health Perspect, 108, 333, 10.1289/ehp.00108333 Brown, 1992, Alcohol consumption and risk of leukemia, non-Hodgkin’s lymphoma, and multiple myeloma, Leuk Res, 16, 979, 10.1016/0145-2126(92)90077-K Mele, 1994, Hair dye use and other risk factors for leukemia and pre-leukemia, Am J Epidemiol, 139, 609, 10.1093/oxfordjournals.aje.a117050 Correa, 2000, Use of hair dyes, hematopoietic neoplasms, and lymphomas: A literature review. I. Leukemias and myelodysplastic syndromes, Cancer Invest, 18, 366, 10.3109/07357900009012180 Caspi, 1995, The association of inflammatory bowel disease and leukemia—Coincidence or not?, Leuk Lymphoma, 17, 255, 10.3109/10428199509056830 Askling, 2005, Risk of haematopoietic cancer in patients with inflammatory bowel disease, Gut, 54, 617, 10.1136/gut.2004.051771 Gentile, 1996, Hepatitis B and C viruses, human T-cell lymphotropic virus types I and II, and leukemias, Cancer Epidemiol Biomarkers Prev, 5, 227 Cooper, 1996, Risk of adult acute leukemia in relation to prior immune-related conditions, Cancer Epidemiol Biomarkers Prev, 5, 867 Parry, 1997, The non-random distribution of point mutations in leukaemia and myelodysplasia—A possible pointer to their aetiology, Leuk Res, 21, 559, 10.1016/S0145-2126(97)83221-3 Wood, 2001, Human DNA repair genes, Science, 291, 1284, 10.1126/science.1056154 Kutler, 2003, A 20-year perspective on the International Fanconi Anemia Registry (IFAR), Blood, 101, 1249, 10.1182/blood-2002-07-2170 Poppe, 2001, Chromosomal aberrations in Bloom syndrome patients with myeloid malignancies, Cancer Genet Cytogenet, 128, 39, 10.1016/S0165-4608(01)00392-2 Song, 1999, Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia, Nat Genet, 23, 166, 10.1038/13793 Gowans, 2005, Genotype-dependent induction of transmissible chromosomal instability by gamma-radiation and the benzene metabolite hydroquinone, Cancer Res, 65, 3527, 10.1158/0008-5472.CAN-04-4242 Boulton, 2003, Low-penetrance genetic susceptibility and resistance loci implicated in the relative risk for radiation-induced acute myeloid leukemia in mice, Blood, 101, 2349, 10.1182/blood-2002-08-2394 Seedhouse, 2004, Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia, Clin Cancer Res, 10, 2675, 10.1158/1078-0432.CCR-03-0372 Larson, 1999, Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia, Blood, 94, 803, 10.1182/blood.V94.2.803 Allan, 2001, Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia, Proc Natl Acad Sci U S A, 98, 11592, 10.1073/pnas.191211198 Worrillow, 2003, An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents, Clin Cancer Res, 9, 3012 Sibley, 2003, Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia, Cancer Res, 63, 4327 Bowen, 2002, Cytochrome P450 1A1 *2B (Val) allele is over-represented in a sub-group of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication, Blood Smith, 2001, Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults, Blood, 97, 1422, 10.1182/blood.V97.5.1422 Bowen, 2003, CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication, Blood, 101, 2770, 10.1182/blood-2002-01-0228 Crane, 1996, Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia, Cancer Epidemiol Biomarkers Prev, 5, 639 Mauritzson, 2002, Leukemia, 16, 2366, 10.1038/sj.leu.2402713 Qian, 2002, Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia, Proc Natl Acad Sci U S A, 99, 14925, 10.1073/pnas.222491799